Emerald Health Biotechnology Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
6
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Emerald Health Biotechnology General Information
Description
Developer of pharmaceutical drugs created to focus on new non-psychotropic cannabinoids for the treatment of inflammatory and neurodegenerative diseases. The company's operations include development of cannabidiol and cannabigerol chemical derivatives that improve the therapeutic properties of the natural hit compounds which addresses unmet clinical need in the treatment of multiple sclerosis, Huntington's disease and scleroderma.
Contact Information
Website
www.vivacellspain.comCorporate Office
- Parque Científico Tecnológico de Córdoba (Rabanales 21)
- Calle Astrónoma Cecilia Payne, Edificio Centauro, Planta 1
- 14014 Cordoba
- Spain
Corporate Office
- Parque Científico Tecnológico de Córdoba (Rabanales 21)
- Calle Astrónoma Cecilia Payne, Edificio Centauro, Planta 1
- 14014 Cordoba
- Spain
Emerald Health Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Emerald Health Biotechnology Comparisons
Industry
Financing
Details
Emerald Health Biotechnology Competitors (24)
One of Emerald Health Biotechnology’s 24 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Cardurion | Venture Capital-Backed | Burlington, MA | ||||
| Ability Pharma | Private Equity-Backed | Barcelona, Spain | ||||
| Gilead Sciences | Formerly VC-backed | Foster City, CA | ||||
| Avalyn Pharma | Venture Capital-Backed | Cambridge, MA |
Emerald Health Biotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Emerald Health Biotechnology Patents
Emerald Health Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3943077-A1 | Use of juniper (juniperus communis) berries extract and agathadiol as positive allosteric modulators of cannabinoid type 1 receptor | Inactive | 22-Jul-2020 | ||
| EP-4167978-A1 | Use of juniper (juniperus communis) berries extract, deoxypodophyllotoxin and agathadiol, as positive allosteric modulators of cannabinoid type 1 receptor | Active | 22-Jul-2020 | ||
| EP-4167978-B1 | Use of juniper (juniperus communis) berries extract, deoxypodophyllotoxin and agathadiol, as positive allosteric modulators of cannabinoid type 1 receptor for treating neuropathic pain and inflammatory pain | Active | 22-Jul-2020 | ||
| EP-4167978-C0 | Use of juniper (juniperus communis) berries extract, deoxypodophyllotoxin and agathadiol, as positive allosteric modulators of cannabinoid type 1 receptor for treating neuropathic pain and inflammatory pain | Active | 22-Jul-2020 | ||
| CA-3175684-A1 | Cannabinoids for use in supressing cancer stem cells | Pending | 29-Apr-2020 | A61K31/05 |
Emerald Health Biotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Emerald Health Biotechnology FAQs
-
When was Emerald Health Biotechnology founded?
Emerald Health Biotechnology was founded in 2003.
-
Where is Emerald Health Biotechnology headquartered?
Emerald Health Biotechnology is headquartered in Cordoba, Spain.
-
What is the size of Emerald Health Biotechnology?
Emerald Health Biotechnology has 6 total employees.
-
What industry is Emerald Health Biotechnology in?
Emerald Health Biotechnology’s primary industry is Drug Discovery.
-
Is Emerald Health Biotechnology a private or public company?
Emerald Health Biotechnology is a Private company.
-
What is the current valuation of Emerald Health Biotechnology?
The current valuation of Emerald Health Biotechnology is .
-
What is Emerald Health Biotechnology’s current revenue?
The current revenue for Emerald Health Biotechnology is .
-
How much funding has Emerald Health Biotechnology raised over time?
Emerald Health Biotechnology has raised $3.43M.
-
Who are Emerald Health Biotechnology’s competitors?
Genentech, Cardurion, Ability Pharma, Gilead Sciences, and Avalyn Pharma are some of the 24 competitors of Emerald Health Biotechnology.
-
When was Emerald Health Biotechnology acquired?
Emerald Health Biotechnology was acquired on 17-May-2018.
-
Who acquired Emerald Health Biotechnology?
Emerald Health Biotechnology was acquired by Emerald Health Research.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
